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We prospectively evaluated if impaired myocardial fatty
acid metabolism is involved in cardiac death after
revascularization by percutaneous coronary artery
intervention in dialysis patients. A cohort of hemodialysis
patients was assessed by dual single-photon emission
computed tomography using the radioiodinated fatty acid
analogue BMIPP and radiolabeled thallium chloride.
Tomography was done within one month before the first
coronary intervention and at the last follow-up angiography
at which neither restenosis nor de novo lesions were
detected. Radiolabel uptake on tomography images was
graded in segments and calculated as summed BMIPP or
thallium scores. Among the 90 hemodialysis patients in the
study, 19 died of cardiac events. Multivariate Cox hazard
analysis found a significant association of cardiac death with
the BMIPP summed scores at the last follow-up angiography.
Kaplan–Meier analysis showed the cardiac death-free survival
rates at 3 years of follow-up were significantly higher in
patients with lower BMIPP summed scores. These results
suggest that myocardial fatty acid imaging may be a useful
test to identify high risk groups of cardiac death in
hemodialysis patients.
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Percutaneous coronary artery intervention (PCI) as well as
coronary artery bypass grafting is an established procedure
for coronary revascularization in patients with end-stage
renal disease (ESRD). Although the initial success of PCI was
comparable between patients with and without ESRD,
coronary restenosis or de novo coronary stenosis occur more
frequently and survival rates are lower among patients with
ESRD.1–4 The study of Hemmelgarn et al.5 found that the
adjusted 8-year survival rates for PCI were significantly lower
for a dialysis group (41.2%) than for a control group without
renal dysfunction (80.4%). The reported 2-year all-cause
survival rate is 48% for dialysis patients after PCI with
stenting.6 Although drug-eluting stents can reduce the rate of
in-stent restenosis compared with bare-metal stents in
patients without ESRD,7,8 PCI with drug-eluting stents
results in higher mortality rates among patients on dialysis
compared with those who are not, despite a similar reduction
in repeat revascularization.9 Furthermore, the incidence of
death or myocardial infarction (MI) does not differ between
dialysis patients fitted with drug-eluting and bare-metal
stents.10 Other factors in addition to restenosis or repeat
revascularization are involved in the lower survival rates of
patients on dialysis who have undergone PCI. We recently
showed that visualizing severely impaired myocardial fatty
acid metabolism on images can help to identify patients at
high risk of cardiac death among those on hemodialysis
without coronary intervention or old MI.11 The present study
evaluates whether impaired myocardial fatty acid metabolism
assessed by imaging can predict cardiac death after coronary
revascularization by PCI among patients on hemodialysis.
RESULTS
After the last follow-up, coronary angiography (CAG) in
which neither coronary restenosis nor de novo lesions were
evident, the study participants routinely underwent echo-
cardiography and dual single-photon emission computed
tomography (SPECT) using the fatty acid analogue, iodine-
123-b-methyl iodophenyl-pentadecanoic acid (BMIPP), and
201thallium chloride (Tl) every 6 months. During follow-up,
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8 of the 98 patients underwent additional PCI to treat
unstable angina pectoris (n¼ 3) or asymptomatic coronary
artery disease identified as worsened BMIPP-Tl SPECT
findings (n¼ 5). Data from these eight patients were not
included in the prognostic portion of the analysis, because
the additional coronary revascularization would have affected
the occurrence of cardiac death among them. Thus, the
resulting study cohort comprised the remaining 90 ESRD
patients undergoing maintenance hemodialysis for a mean
of 105±93 months (male/female: 64/26; mean age: 65±9
years). The mean duration of follow-up after confirmation of
coronary revascularization (last follow-up CAG) was 2.7±1.4
years. The etiology of renal failure involved diabetes mellitus
in 57.8% (52/90), chronic glomerular disease in 38.9%
(35/90), polycystic kidney disease in 2.2% (2/318), and
nephrosclerosis in 1.1% (1/90) of the patients.
Cardiac death and baseline characteristics
Of the 90 participants, 19 (21.1%) died of cardiac events
(acute MI, n¼ 3; congestive heart failure, n¼ 2; cardiac
sudden death, n¼ 14) during a mean follow-up period of
2.7±1.4 years. After the onset of acute MI, all three patients
had undergone emergency CAG and direct PCI, but cardiac
death resulted within 24 h after PCI. The mean values of
patients who died of cardiac events revealed that they were
older, and that the ratio of female gender, the mean BMIPP
summed score, and BMIPP-Tl mismatch score at the last
follow-up CAG were higher, whereas the ratio of a history of
alcohol consumption and diastolic blood pressure before
dialysis were lower than in those who did not die in this
manner (Tables 1 and 2). We found no difference between
patients with and without cardiac death in terms of mean
values of dialysis duration, body mass index, systolic blood
pressure before dialysis, cardiothoracic ratio, left ventricular
(LV) ejection fraction, LV mass index, blood hemoglobin
concentration, serum concentrations of albumin, total
cholesterol, high-density lipoprotein-cholesterol, triglyceride,
calcium, inorganic phosphorus, intact parathyroid hormone,
high-sensitivity C-reactive protein or hemoglobin A1c, and
ratios of diabetes mellitus, smoking habit, or prescribed
medications such as calcium channel blockers, angiotensin-I-
converting enzyme inhibitors, angiotensin II type-1 receptor
blockers, a1-blockers, b-blockers, nitrates, antiplatelet drugs,
anticoagulants, and statins. We found no difference between
patients with and without cardiac death in terms of mean
number of repeat PCI, use of rotablator, and the incidences of
multivessel, right coronary artery, left circumflex artery, and
de novo coronary lesions and restenosis, whereas the
incidence of left anterior descending artery lesions tended
Table 1 | Clinical characteristics of hemodialysis patients with or without cardiac death after coronary revascularization
Cardiac death (+) Cardiac death ()
(n=19) (n=71) P-values
Age (years) 69.9±7.6 63.9±9.1 0.010
Female gender 9/19 (47.4%) 54/71 (23.9%) 0.046
Dialysis duration (months) 104.9±97.6 105.5±92.2 0.983
Smoking habit 8/19 (42.1%) 32/1 (43.7%) 0.820
Alcohol consumption 3/19 (15.8%) 31/71 (43.7%) 0.026
Diabetes mellitus 13/19 (68.4%) 39/71 (54.9%) 0.296
Systolic blood pressure before dialysis (mm Hg) 146±17 146±14 0.899
Diastolic blood pressure before dialysis (mm Hg) 369±12 74±11 0.042
Left ventricular ejection fraction (%) 360.3±14.3 59.7±13.8 0.866
Left ventricular mass index (g/m2) 151.2±60.1 168.8±91.3 0.431
PCI
Number of repeat PCI 2.2±1.5 32.8±2.1 0.290
Use of rotablator 10/19 (52.6%) 39/71 (54.9%) 0.860
Multivessel lesions 11/19 (57.9%) 47/71 (66.2%) 0.507
Right coronary artery lesion 11/19 (57.9%) 41/71 (57.8%) 0.991
Left anterior descending artery lesion 9/19 (47.4%) 50/71 (70.4%) 0.061
Left circumflex artery lesion 14/19 (73.7%) 48/71 (67.6%) 0.616
Restenosis 11/19 (57.9%) 32 /71 (45.1%) 0.326
De novo coronary stenosis (450%) 5/19 (26.3%) 31/71 (43.7%) 0.174
CRP, C-reactive protein; HDL, high-density lipoprotein; PCI, percutaneous coronary intervention.
Smoking habit defined as 410 cigarettes per week; alcohol consumption defined as 420 g of alcohol per week.
Table 2 | SPECT findings of hemodialysis patients with or
without cardiac death after coronary revascularization
Cardiac
death (+)
Cardiac
death ()
(n=19) (n=71) P-values
Before first PCI
BMIPP summed score 19.3±8.0 21.2±10.1 0.455
Tl summed score 7.6±6.2 7.6±7.2 0.989
BMIPP-Tl mismatch score 11.7±4.4 13.6±7.2 0.272
At last follow-up CAG
BMIPP summed score 25.2±7.4** 14.6±6.1** o0.0001
Tl summed score 4.8±4.3* 4.9±4.6** 0.915
BMIPP-Tl mismatch score 20.4±5.0** 9.7±5.1** o0.0001
BMIPP, iodine-123-b-methyl iodophenyl-pentadecanoic acid; CAG, coronary angio-
graphy; PCI, percutaneous coronary artery intervention; SPECT, single-photon
emission computed tomography; Tl, 201thallium chloride.
*Po0.05, **Po0.01 compared with values before first PCI using paired t-test.
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to be lower in patients with, than without, cardiac death
(Table 1). Of the patients with cardiac death after complete
coronary revascularization, the mean BMIPP summed score
and the mean BMIPP-Tl mismatch score were higher at the
last follow-up CAG than before the first PCI, but the mean Tl
summed score was lower at the last follow-up CAG than
before the first PCI (Table 2). In contrast, the mean values of
BMIPP summed score, Tl summed score, and BMIPP-Tl
mismatch scores were all lower at the last follow-up CAG
than before the first PCI among patients without cardiac
death after coronary revascularization (Table 2). Figure 1
shows dual BMIPP and Tl SPECT images before the first PCI
and at the last follow-up CAG in a patient who progressed to
cardiac death after revascularization by PCI and in a patient
without cardiac death after coronary revascularization.
Association between baseline characteristics and
subsequent cardiac death
Univariate Cox’s hazard analysis of cardiac death after
revascularization (Table 3) showed that the BMIPP summed
score at the last follow-up CAG, the BMIPP-Tl mismatch
score at the last follow-up CAG, and age were positively asso-
ciated with cardiac death, whereas alcohol consumption
and diastolic blood pressure before dialysis were inversely
associated. Female gender, left anterior descending artery
lesion, LV mass index, and restenosis tended to be associated
with cardiac death. Multivariate Cox’s hazard analysis of
these factors revealed that BMIPP summed score at the last
follow-up CAG (hazard ratio (HR)¼ 1.169) or BMIPP-Tl
mismatch score at the last follow-up CAG (HR¼ 1.257) were
independently associated with cardiac death after revasculari-
zation (Table 4a and b). Univariate Cox’s hazard analysis
showed that female gender (HR¼ 3.791; 95% confidence
interval (CI): 1.237–11.615), alcohol consumption (HR¼
0.121; 95% CI: 0.016–0.939), left anterior descending artery
lesion (HR¼ 0.188; 95% CI: 0.056–0.637), BMIPP summed
score at the last follow-up CAG (HR¼ 1.168; 95% CI:
1.070–1.276), and the BMIPP-Tl mismatch score at the last
follow-up CAG (HR¼ 1.203; 95% CI: 1.099–1.316) were
significantly associated with cardiac death after revasculari-
zation in the diabetic subgroup (n¼ 52). Multivariate Cox’s
hazard analysis of these factors showed that either BMIPP
summed score at the last follow-up CAG (HR¼ 1.110; 95%
CI: 1.009–1.220) or BMIPP-Tl mismatch score at the last
follow-up CAG (HR¼ 1.178; 95% CI: 1.031–1.347) was
independently associated with cardiac death after revasculari-
zation. In nondiabetic subgroup (n¼ 38), in contrast,
only the BMIPP summed score (HR¼ 1.292; 95% CI:
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Figure 1 | Dual BMIPP and Tl SPECT images. BMIPP and Tl SPECT images from a patient who progressed to cardiac death after coronary
revascularization by PCI (a) and from a patient who did not die after coronary revascularization by PCI (b). (a) Non-diabetic 56-year-old
female patient who had undergone hemodialysis for 48 months at the time of first PCI. CAG before the first PCI revealed significant stenosis
in right coronary artery no. 1, 90%). This lesion was revascularized by PCI with rotational atherectomy and stenting, but she underwent
four additional PCIs due to in-stent restenoses of this lesion and de novo lesions in left circumflex artery. Cardiac sudden death occurred
at 123 days after the last follow-up CAG. BMIPP summed score and Tl summed score were 12 and 7 before the first PCI, and 34 and 22 at the
final follow-up CAG, respectively. (b) Non-diabetic 74-year-old male patient who had undergone hemodialysis for 8 months at the time
of first PCI. CAG before the first PCI revealed significant stenoses in right coronary no. 2, 99%; no. 3, 100%), left anterior descending
no. 6, 75%; no. 9, 90%), and left circumflex (high lateral, 90%) arteries. These lesions were all revascularized by PCI with rotational
atherectomy and stenting, but he received eight additional PCIs due to restenosis of these lesions or de novo lesions in all three coronary
arteries. He remained alive at the end of the study (619 days after last follow-up CAG). BMIPP summed score and Tl summed score were
28 and 12 before the first PCI, and 8 and 6 at the last follow-up CAG, respectively.
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1.092–1.528) and the BMIPP-Tl mismatch score (HR¼ 1.350;
95% CI: 1.110–1.641) at the last follow-up CAG were
significantly associated with cardiac death after revascular-
ization according to univariate Cox’s hazard analysis.
SPECT findings and cardiac death
Receiver operating characteristic analysis showed that the
BMIPP summed score and BMIPP-Tl mismatch score at the
last follow-up CAG had the potential to predict cardiac death
after revascularization (Figure 2). When cutoff values were
established at 20 for the BMIPP summed score and at 14 for
the BMIPP-Tl mismatch score by receiver operating char-
acteristic analysis, the sensitivity and specificity of BMIPP
SPECT and BMIPP-Tl mismatch of predicting cardiac death
after revascularization were 78.9 and 80.3%, and 94.7 and
78.9%, respectively. Kaplan–Meier survival estimates revealed
that the event-free rates of cardiac death at 3 years were 36.2
and 95.1% in patients with summed BMIPP scores ofX20 or
o20, respectively (Figure 3a), and 43.1 and 98.2% in patients
with BMIPP-Tl mismatch scores of X14 and o14,
respectively (Figure 3b). The incidences of in-stent restenosis
or de novo coronary lesions, numbers of repeat PCI, or use of
the rotablator were not significantly associated with the
BMIPP summed score and the BMIPP-Tl mismatch score at
the last follow-up CAG. Age was significantly correlated with
the BMIPP summed score at the last follow-up CAG (r¼ 345,
P¼ 0.001), the BMIPP-Tl mismatch score at the last follow-
up CAG (r¼ 384, P¼ 0.0001), and difference of BMIPP
summed scores between before the first PCI and at the last
follow-up CAG (r¼ 274, P¼ 0.009).
SPECT findings and eccentric left ventricular hypertrophy
Eccentric left ventricular hypertrophy determined by echo-
cardiography was identified in 6 women and 17 men among
the study participants (n¼ 23) at the last follow-up CAG.
The mean values of Tl summed scores (5.4±4.6 (n¼ 23) vs
Table 3 | Univariate Cox’s hazard analysis of cardiac death after revascularization*
Hazard ratio 95% confidence interval P-value
BMIPP summed score at last follow-up CAG 1.197 1.116–1.285 o0.0001
BMIPP-Tl mismatch score at last follow-up CAG 1.244 1.151–1.345 0.0001
Age (1 year) 1.069 1.012–1.129 0.0168
Alcohol consumption (0: no, 1: yes) 0.584 0.083–0.974 0.0456
Diastolic blood pressure before dialysis (1 mm Hg) 0.949 0.906–0994 0.0273
Female gender (0: male, 1: female) 2.293 0.930–5.650 0.0710
Left anterior descending artery lesion (0: no, 1: yes) 0.451 0.183–1.111 0.0834
Left ventricular mass index (1 g/m2) 0.991 0.982–1.000 0.0628
Restenosis (0: no, 1: yes) 2.184 0.867–5.502 0.0970
BMIPP, iodine-123-b-methyl iodophenyl-pentadecanoic acid; CAG, coronary angiography; Tl, 201thallium chloride.
*Po0.1.
Table 4 | Multivariate Cox’s hazard analysis
Hazard ratio 95% confidence interval P-value
(a) Inclusion of BMIPP summed score at last follow-up CAG
BMIPP summed score at last follow-up CAG 1.184 1.096–1.279 o0.0001
Age (1 year) 0.991 0.933–1.053 0.779
Alcohol consumption (0, no; 1, yes) 0.564 0.152–2.093 0.392
Diastolic blood pressure before dialysis (1 mm Hg) 0.981 0.937–1.026 0.401
Hazard risk 95% confidence interval P-value
(b) Inclusion of BMIPP-Tl mismatch score at last follow-up CAG
BMIPP-Tl mismatch score at last follow-up CAG 1.270 1.146–1.408 o0.0001
Age (1 year) 0.993 0.936–1.061 0.907
Alcohol consumption (0: no, 1: yes) 1.512 0.340–6.729 0.587
Diastolic blood pressure before dialysis (1 mm Hg) 1.006 0.965–1.049 0.765
BMIPP, iodine-123-b-methyl iodophenyl-pentadecanoic acid; CAG, coronary angiography; Tl, 201thallium chloride.
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Figure 2 | Receiver operating characteristic curves indicating
potential to predict cardiac death after coronary
revascularization among BMIPP SPECT, Tl SPECT, and
BMIPP-Tl mismatch. Area under the curve (AUC) was 0.872 for
BMIPP, 0.501 for Tl SPECT, and 0.931 for BMIPP-Tl mismatch.
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4.7±4.5 (n¼ 67)), BMIPP summed scores (17.2±8.2
(n¼ 23) vs 16.7±7.6 (n¼ 67)), and BMIPP-Tl mismatch
scores (11.7±5.9 (n¼ 23) vs 12.0±7.0 (n¼ 67)) at the last
follow-up CAG did not significantly differ between patients
with and without eccentric left ventricular hypertrophy.
DISCUSSION
Of 90 hemodialysis patients who had achieved complete
coronary revascularization by single or repeat PCI, 19 died of
cardiac-related causes during a 2.7±1.4-year follow-up.
Cardiac sudden death accounted for a significant proportion
of the cardiac death. Multivariate Cox’s hazard analysis
showed that cardiac death was significantly associated not
with the number of repeat PCI or revascularizations due to
restenosis or de novo coronary lesions, but with reduced
BMIPP uptake in SPECT and a large BMIPP-Tl mismatch at
the last follow-up CAG. Kaplan–Meier survival estimates
revealed that the event-free rate of cardiac death was
significantly lower among patients with a BMIPP summed
score of X20 and in those with a BMIPP-Tl mismatch score
of X14. Highly impaired myocardial fatty acid metabolism
determined by BMIPP SPECT and a large BMIPP-Tl
mismatch might be involved in the occurrence of cardiac
death after coronary revascularization by PCI among patients
on hemodialysis.
The energy required by the normal myocardium is mainly
derived from the b-oxidation of free fatty acids under aerobic
conditions.12 Under hypoxic or ischemic conditions, fatty
acid oxidation is suppressed and replaced by glucose
oxidation, which consumes less oxygen.13 123I-BMIPP is a
branched free fatty acid analogue characterized by resistance
to b-oxidation. BMIPP SPECT imaging mainly indicates the
accumulation of acetyl BMIPP in the lipid pool of
cardiomyocytes, whereas the myocardial ATP content plays
a key role in the accumulation of acetyl BMIPP in the lipid
pool. Thus, a decrease in the myocardial ATP content leads to
reduced BMIPP uptake in SPECT images.14–20 Myocardial
ischemia reduces the myocardial lipid pool through a shift
from lipid to glucose metabolism, and decreases myocardial
ATP content, which would inhibit acetyl BMIPP synthesis
and further decrease acetyl BMIPP accumulation in the
reduced lipid pool. Therefore, reduced uptake of BMIPP in
SPECT is thought to indicate decreased fatty acid oxidation
and ATP content in the myocardium, which are mainly
caused by myocardial ischemia.
Intramyocardial arteriolar thickening, reduced capillary
density, and myocardial fibrosis are pathological character-
istics of the hearts of dialysis patients.21–27 Such myocardial
abnormalities in these patients are likely to cause myocardial
microcirculatory disturbances. Recent studies have empha-
sized the ubiquitous occurrence of distal embolization of
atheromatous and thrombotic debris at PCI, which poten-
tially results in microcirculatory disturbances, abnormal
myocardial metabolism, and increased myonecrosis.28–30
The embolization of atheromatous and thrombotic debris
caused by PCI procedures seems to aggravate myocardial
microcirculation and to impair myocardial fatty acid
metabolism in hemodialysis patients, even if epicardial
coronary lesions are revascularized and myocardial necrosis
does not occur. Damaged microcirculation and impaired
fatty acid metabolism in the myocardium caused by PCI are
thought to generally persist for a long time, but the present
results show that they can apparently recover within relatively
short periods such as 6 months after PCI in some
hemodialysis patients. Age may be partly involved in the
recovery or persistence of myocardial microcirculatory
disturbances and impaired myocardial fatty acid metabolism
after PCI among this population, because age was signifi-
cantly correlated with the BMIPP summed score, BMIPP-Tl
mismatch score at the last follow-up CAG, and the difference
of BMIPP summed scores between before the first PCI and at
the last follow-up CAG.
Whereas the Tl summed score at the last follow-up CAG
was not related to cardiac death after revascularization, a
BMIPP-Tl mismatch score at the last follow-up CAG was
associated with cardiac death among patients on hemodia-
lysis after revascularization. The area of the BMIPP and Tl
BMIPP SPECT before the last follow-up CAG
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Figure 3 | Changes in cardiac death-free survival. Kaplan–Meier
analysis of cardiac death-free survival rates according to BMIPP
SPECT (a) or BMIPP-Tl mismatch (b) before last follow-up CAG.
(a) Event-free survival rates of cardiac death at 3 years among
patients with BMIPP summed scores of X20 and o20 were 36.2
and 95.1%, respectively. Log-rank test, Po0.0001. (b) Event-free
survival rates of cardiac death at 3 years among patients with
BMIPP-Tl mismatch scores ofX14 ando14 were 43.1 and 98.2%,
respectively. Log-rank test, Po0.0001.
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mismatch was a histological mixture of myocardium and
fibrous tissue that was identified only in the ischemic myo-
cardium when the extent of fibrotic change was o20%.31
Positron emission tomography has demonstrated that areas
with a mismatch absorb high levels of 18F-fluorodeoxy-
glucose.32 Because we excluded patients with old MI
or myocardial necrosis at PCI from the study and because
complete revascularization by CAG within 1 month of the
SPECT evaluation was confirmed in our patients, we postu-
late that a large BMIPP-Tl mismatch at the last follow-
up CAG indicates myocardial ischemia induced mainly by
a microcirculatory disturbance, although the contribution
of repeated coronary spasm cannot be eliminated.33,34
The present study has several limitations. The mean age of
the study participants was relatively high at 64 years.
Advanced age is generally an independent risk factor for
cardiac death, and age was associated with cardiac death in
the present study. The ratio of female-to-male gender was not
equal and that of diabetic patients was over half. We consi-
dered sudden death as cardiac death although a coronary
origin was not clearly determined. Because SPECT analyses
are now semiquantitative, the summed scores of BMIPP, Tl,
or BMIPP-Tl mismatch might differ among institutions.
Finally, the study cohort was too small to define how
impaired myocardial fatty acid metabolism is involved in
cardiac death after coronary revascularization in patients on
hemodialysis. A larger patient population is needed to
establish the clinical implications and prognostic value of
this method.
We discovered that highly abnormal BMIPP SPECT find-
ings and a large mismatch between BMIPP and Tl SPECT
values might be useful for identifying hemodialysis patients
at high risk of cardiac death after coronary revascularization
by PCI. Because findings of reduced BMIPP uptake on
images and an increased BMIPP-Tl mismatch are thought to
indicate decrease in myocardial fatty acid oxidation mainly
caused by myocardial ischemia, impaired fatty acid metabo-
lism, and a microcirculatory disturbance in the myocardium
might be involved in the lower mortality after PCI in this
population. Whether cardiac death after coronary revasculari-
zation can be reduced to improve reduced myocardial fatty
acid oxidation by increasing myocardial microcirculation in
hemodialysis patients requires further investigation.
MATERIALS AND METHODS
Patients
Figure 4 summarizes the entry and exclusion criteria for the study.
One hundred and twenty-eight patients with ESRD and stable
coronary artery disease on maintenance hemodialysis at Toujinkai
Hospital underwent a successful first PCI with bare-metal stents
between 1 July 2001 and 31 December 2003. All 128 patients were
evaluated by BMIPP-Tl dual SPECT within 1 month before the first
128 hemodialysis patients, who had undergone the first PCI between July 2 2001 and December 31 2003,
+ BMIPP-TI SPECT within 1 month before first PCI.
Excluded
Enrolled
98 patients on hemodialysis
• Confirmation of complete revascularization by CAG
from January 1 2002 to December 31 2004
• BMIPP-TI SPECT examination within 1 month 
before last follow-up CAG
3 patients: who died before last follow-up CAG
4 patients: incomplete revascularization due to 
restenosis or de novo lesion during study
7 patients: who refused SPECT within 1 month
before the last follow-up CAG
16 patients: myocardial necrosis at PCI
From January 1 2002 to December 31 2004
Follow-up: Until December 31 2006
Figure 4 | Inclusion and exclusion of study participants. PCI, percutaneous coronary intervention; CAG, coronary angiography.
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PCI. Patients with moderate or worse cardiac valvular disease or old
MI at the first PCI were excluded from the study participants. Of
these, 78 had to undergo repeat PCI at least twice due to in-stent
restenosis or de novo coronary lesions that were discovered at follow-
up CAG 6 months after each PCI. The follow-up CAG, at which
complete revascularization after PCI (absence of restenosis and
de novo coronary lesions) was confirmed, was designated as the last
follow-up CAG. Of these 128 patients, 3 died before the last follow-
up CAG due to noncardiac causes, revascularization was incomplete
in 4 due to repeated restenoses or de novo coronary lesions during
the study period, 7 refused the SPECT examination within 1 month
before the last follow-up CAG, and 16 had myocardial necrosis at
the time of PCI. Myocardial necrosis at PCI was diagnosed when
coronary reflow was not established during PCI, new ST-T changes
were evident on electrocardiograms, and serum concentrations of
troponin-T and creatine phosphokinase-MB fraction were signifi-
cantly elevated within 24 h of PCI. These 30 patients were excluded
from the study. Consequently, 98 patients on hemodialysis in whom
complete revascularization was achieved by one or more PCI and
who had been evaluated by dual BMIPP-Tl SPECT within 1 month
before the first PCI and the last follow-up CAG were enrolled in the
study (male/female: 69/29; mean age: 64±9 years; mean dialysis
duration: 104±89 months). The study participants were enrolled
at the time of the last follow-up CAG (from January 1 2002 to
December 31 2004), and the patients were followed up through
December 31 2006, until the end point described below was
reached. Of the 98 patients, 56 had type II diabetes mellitus (57.1%).
Their mean serum hemoglobin A1c values were 5.8±0.8%.
Blood pressure was measured hourly during dialysis using a
mercury sphygmomanometer, and blood pressure was determined
as the mean of all measurements obtained during dialysis sessions
over a period of 2 weeks before the last follow-up CAG. The
cardiothoracic ratio and body mass index were measured within
1 month before the last follow-up CAG. A history of cigarette
smoking or alcohol consumption was ascertained from a ques-
tionnaire. Smoking habit means 10 or more cigarettes per week
and alcohol consumption means intake of at least 20 g of alcohol
per week. The Ethics Committee for Human Research of Toujinkai
Hospital approved the study protocol, and all patients provided
written, informed consent to participate in all procedures associated
with the study.
Stent implantation and angiographic follow-up
Both PCI and follow-up CAG proceeded at the Department of
Interventional Cardiology of Kyoto Second Red Cross Hospital. All
patients with coronary artery disease who underwent PCI with
stenting were medicated with intravenous heparin and antiplatelet
therapy (200 mg/day of ticlopidine hydrochloride plus 100–200 mg/
day of aspirin). Customized bare-metal stents mounted on
expandable balloons were implanted and drug-eluting stents were
not applied in this study. The minimal and mean balloon inflation
pressures were 13 and 19.2±3.1 atm, respectively. Distal protection
devices were not used during the PCI procedures. Stenting was
successful in all 98 patients. Experienced interventional cardiologists
performed quantitative follow-up CAG at 6 months after coronary
stenting using a validated automated edge-detection program
(CCIP-310/W; CATHEX, Tokyo, Japan). Coronary in-stent rest-
enosis was defined as stenosis of 450% diameter in the stent at
follow-up CAG. Coronary lesions with stenosis of 450% diameter
that were newly identified at follow-up CAG were defined as de novo
coronary stenosis.
Radionuclide imaging
All patients underwent resting 123I-BMIPP and 201Tl dual myocardial
scintigraphy after fasting for over 6 h on a midweek, non-dialysis day
within 1 month before the first PCI and within 1 month before
the last follow-up CAG. Details of the dual BMIPP-Tl SPECT
procedure are described elsewhere.11,35 The images were divided into
17 segments for semiquantitative analysis according to the standard
myocardial segmentation for tomographic heart imaging established
by the American Heart Association.36 The amount of radioactivity
taken up by each segment was visually graded and assigned a score
from 0 to 4 (uptake: 0, normal; 1, mildly reduced; 2, moderately
reduced; 3, severely reduced; and 4, none). The BMIPP and Tl SPECT
scores for 17 myocardial segments were designated as the summed
BMIPP and Tl scores, respectively. A BMIPP-Tl mismatch was defined
as a difference between summed BMIPP and Tl scores. The same
experienced technician performed all the scintigraphic procedures. All
BMIPP and Tl SPECT images were interpreted within 1 week of the
SPECT examination by the same two investigators who were blinded
to the clinical and laboratory information of the patients.
Echocardiography
The patients underwent two-dimensionally guided M-mode echo-
cardiography using a single ultrasonographic recorder (UF-8800;
Fukuda Denshi, Tokyo, Japan) on a midweek nondialysis day within
1 month before the last follow-up CAG as described.11,35,37 Relative
LV wall thickness was calculated as 2 LV posterior wall thickness/
LV end-diastolic dimension. Criteria for left ventricular hypertrophy
were LV mass index exceeding 134 g/m2 in men or 110 g/m2
in women. Eccentric left ventricular hypertrophy was defined
when relative LV wall thickness was o0.45 and LV dilation
(LV end-diastolic dimension 456 mm).
Biochemical and hematological determinations
Blood samples (10 ml) were collected at the midweek hemodialysis
sessions within 2 weeks before the last follow-up CAG. We measured
blood hemoglobin levels, serum concentrations of total cholesterol,
high-density lipoprotein-cholesterol, triglyceride, albumin, calcium,
inorganic phosphorus, intact parathyroid hormone, high-sensitivity
C-reactive protein, and the hemoglobin A1c concentration.
End point
All 90 patients were followed up at Toujinkai Hospital after the last
follow-up CAG. The end point was cardiac-derived death, namely
cardiac sudden death and death due to acute MI or congestive heart
failure. Cardiac sudden death was defined as death within 24 h of the
time that the victim was last seen alive in a normal state of health,
and cardiac diseases such as arrhythmias or acute coronary
syndrome were considered the most frequent causes of death. Acute
MI was diagnosed when new abnormal Q waves appeared on
electrocardiograms together with anterior chest pain or discomfort,
when abnormal LV wall motion was recognized by echocardio-
graphy, and when serum concentrations of troponin-T and creatine
phosphokinase-MB fraction were significantly elevated. Cardio-
logists at Toujinkai Hospital or at the Kyoto Second Red Cross
Hospital diagnosed cardiac-derived death, and they did not know
the SPECT findings at the point of diagnosis.
Statistical analysis
Values are expressed as means±s.d. We compared the means
of continuous variables using unpaired or paired t-tests, and cate-
gorical data were analyzed using the w2 test. Thresholds for
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continuous variables were defined and the predictive potential was
compared among the BMIPP summed score, Tl summed score, or
BMIPP-Tl mismatch score for cardiac death using receiver operating
characteristic analysis. This analysis provided optimal sensitivity and
specificity in predicting cardiac death. Thresholds were obtained
from minimal false-positive and false-negative results, that is,
by minimizing the expression (1specificity)2þ (1sensitivity)2.
We analyzed survival using the Kaplan–Meier analysis and event-free
survival using the log-rank test. Multivariate analysis of prognosis
was assessed using the Cox proportional hazard model. A P-value of
o0.05 was considered significant. All data were statistically analyzed
by individuals without knowledge of the SPECT findings and the
patients’ profiles.
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